InsidersTradesSigma
Track the 명인제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 명인제약 has logged 1 insider filings. Market capitalisation: €616.1bn. The latest transaction was filed on 6 April 2026 (Mixed). Among the most active insiders: 이동철. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Myungjin Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the XKRX market.